Ornrat Lohitnavy
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 4
- Antibiotics Pharmacokinetics and Efficacy 4
- Drug-Induced Hepatotoxicity and Protection 2
-
- Pharmacogenetics and Drug Metabolism 4
- Antibiotics Pharmacokinetics and Efficacy 4
- Drug-Induced Hepatotoxicity and Protection 2
-
- Pneumonia and Respiratory Infections 3
-
- Drug Transport and Resistance Mechanisms 3
-
- Carcinogens and Genotoxicity Assessment 2
-
- Glutathione Transferases and Polymorphisms 2
-
- Antimicrobial Resistance in Staphylococcus 2
- Co-authors
- Manupat LohitnavyBrad ReisfeldWimonchat TangamornsuksanNathorn ChaiyakunaprukC. Norman ScholfieldRaymond S. H. YangRosarin SruamsiriLaura Chubb
- Partner nations
- ThailandUnited StatesMalaysia
In The Last Decade
Ornrat Lohitnavy
22 papers receiving 345 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 44
- Health, Toxicology and Mutagenesis 52
- Pharmacology 55
- Toxicology 11
- Pharmaceutical Science 18
Countries citing papers authored by Ornrat Lohitnavy
This map shows the geographic impact of Ornrat Lohitnavy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ornrat Lohitnavy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ornrat Lohitnavy more than expected).
Fields of papers citing papers by Ornrat Lohitnavy
This network shows the impact of papers produced by Ornrat Lohitnavy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ornrat Lohitnavy. The network helps show where Ornrat Lohitnavy may publish in the future.
Co-authorship network
The 21 scholars most cited alongside Ornrat Lohitnavy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2021 | 2 | |
| 4 | 2018 | 66 | |
| 5 | 2017 | 9 | |
| 6 | 2017 | 4 | |
| 7 | 2015 | 66 | |
| 8 | 2015 | 30 | |
| 9 | 2011 | 7 | |
| 10 | 2011 | 7 | |
| 11 | 2008 | 22 | |
| 12 | 2007 | 3 | |
| 13 | 2007 | 26 | |
| 14 | 2006 | 14 | |
| 15 | 2005 | 45 | |
| 16 | 2003 | 15 | |
| 17 | 2003 | 5 | |
| 18 | Pharmacokinetic and bloequivalence studies of generic clarithromycin tablets in healthy male volunteers. | 2003 | 1 |
| 19 | 2003 | 11 | |
| 20 | Increase in lactate dehydrogenase isoenzyme-4 and splenocyte toxicity in methomyl-treated rats. | 1998 | 11 |
About Ornrat Lohitnavy
Ornrat Lohitnavy is a scholar working on Pharmacology, Biological Psychiatry and Pharmacology, having authored 22 papers that have together received 355 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Pneumonia and Respiratory Infections (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Carcinogens and Genotoxicity Assessment (2 papers), Glutathione Transferases and Polymorphisms (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Pharmacology (44 citations), Health, Toxicology and Mutagenesis (52 citations) and Pharmacology (55 citations). Ornrat Lohitnavy has collaborated with scholars based in Thailand, United States and Malaysia. Frequent co-authors include Manupat Lohitnavy, Brad Reisfeld, Wimonchat Tangamornsuksan, Nathorn Chaiyakunapruk, C. Norman Scholfield, Raymond S. H. Yang, Rosarin Sruamsiri, Laura Chubb, Yasong Lu and Melvin E. Andersen. Their work appears in journals such as PLoS ONE, Scientific Reports and Toxicological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.